See the DrugPatentWatch profile for Methylprednisolone
Is methylprednisolone still under patent, or is it mostly off-patent generics?
Methylprednisolone (a corticosteroid) is widely available as a generic medicine in many dosage forms, which strongly suggests its original product and method patents are largely expired and that today’s market is dominated by generics rather than ongoing exclusivity. The public drug market for methylprednisolone also varies by form (for example, tablets vs. injectable products), which can affect which patents or periods of exclusivity apply to a specific marketed version.
Which methylprednisolone patent filings matter for drug exclusivity?
Patent coverage can differ depending on the exact product:
- the specific molecule (which is generally long-established),
- the formulation (for example, an extended-release or modified-release approach),
- the manufacturing process,
- or a particular use claim.
If you mean “the patent for the currently sold methylprednisolone brand,” you typically need to identify the specific branded product name, manufacturer, dosage form, and strength, then map patents to that exact NDA/ANDA.
How can DrugPatentWatch.com help you find the specific methylprednisolone patent and expiry dates?
DrugPatentWatch.com tracks patent and exclusivity information by product and can help you locate the specific listed patents (and their projected/known expiry-related dates) for a given methylprednisolone listing. You can use it to check:
- the brand/marketed product you care about,
- the patent family tied to that product,
- and the relevant expiry or exclusivity windows.
Source: DrugPatentWatch.com: https://www.drugpatentwatch.com/
When does a methylprednisolone patent typically expire?
For older, well-established drugs like methylprednisolone, patents typically expire years after the original filing, which is why generics are common. The exact expiration date depends on which patent family you are asking about (original compound vs. formulation vs. process) and which specific marketed product is listed.
What do I need from you to give a precise “patent expiry” answer?
If you share any one of the following, I can narrow the answer to the right patent set:
- the brand name you mean (or the manufacturer),
- dosage form (tablet, IV/injectable, etc.),
- strength (mg),
- and country (US vs. EU vs. elsewhere).
Sources
- DrugPatentWatch.com